Lead
Dr. Salvador Plasencia, a Santa Monica physician, was sentenced on Wednesday to 30 months in federal prison after pleading guilty to distributing ketamine that prosecutors say helped fuel the addiction and eventual overdose death of actor Matthew Perry in 2023. The sentence — the first handed down in the multiyear federal probe into how Perry obtained the dissociative anaesthetic — also included a $5,600 fine and immediate federal custody. Family members of the 54-year-old Friends star urged the judge for a substantial sentence, saying Plasencia repeatedly supplied Perry despite signs of addiction. Plasencia expressed regret in court and said he had surrendered his medical license; four others charged in the investigation have pleaded guilty and face upcoming sentencing.
Key takeaways
- Dr. Salvador Plasencia was sentenced to 30 months in federal prison and ordered to pay a $5,600 fine; he was taken into custody immediately after the ruling.
- Plasencia pleaded guilty to four counts of distributing ketamine; the charges carried a theoretical maximum of 40 years, while prosecutors sought a three-year term.
- Matthew Perry, 54, was found dead at his Los Angeles home in 2023 after longstanding struggles with depression and addiction; authorities tied illicit ketamine supplies to his death.
- Court documents state Plasencia sold about twenty 5 ml (100 mg/ml) vials, ketamine lozenges and syringes to Perry and his assistant between 30 September and 12 October 2023.
- Prosecutors allege Plasencia injected Perry at the actor’s home and in a Long Beach aquarium parking lot, and trained Perry’s assistant to administer doses.
- Five people were charged in the federal probe; four others — including another doctor, an assistant and two suppliers described in filings — have pleaded guilty and await sentencing.
Background
Ketamine is a dissociative anaesthetic with established medical uses, including as an off-label treatment for severe depression when administered in controlled clinical settings. Over recent years, high-profile cases and growing demand for rapid-acting antidepressants have put pressure on clinicians and clinics to expand ketamine access, sometimes stretching established safeguards. Matthew Perry, well-known for his role as Chandler Bing, had publicly detailed long-running battles with depression and substance use; court filings show he obtained legally prescribed ketamine but later sought additional supplies beyond prescribed amounts.
The federal investigation that culminated in these charges described an underground supply chain in Los Angeles that prosecutors said capitalised on Perry’s addiction. Investigators identified multiple intermediaries and alleged sellers, including a figure prosecutors dubbed the “Ketamine Queen,” operating from a Los Angeles residence. Five defendants were charged after a multiyear probe into how Perry accessed the drug outside regulated channels, reflecting wider concerns about diversion of controlled substances from medical settings to illicit distribution.
Main event
In federal court in Los Angeles, Judge Sherilyn Peace Garnett sentenced Plasencia to 30 months after he admitted guilt over the summer to four counts of distributing ketamine. Prosecutors had recommended a three-year sentence; the statutory exposure listed in indictments reached as high as 40 years, but plea agreements typically narrow potential penalties. Alongside prison time, the court imposed a $5,600 restitution fine and immediately remanded Plasencia to federal custody.
Family members read victim impact letters and spoke in court, urging a strict sentence. Perry’s mother, Suzanne Morrison, referenced text messages included in filings in which Plasencia disparaged her son and discussed possible payment for drugs; she told the court that a physician had a duty to protect. Perry’s father and stepmother also submitted written statements describing the family’s devastation and calling Plasencia “most culpable” for exploiting Perry’s vulnerabilities.
Court records detail how Plasencia — sometimes called “Dr. P” in filings — allegedly injected Perry in private settings and supplied both vials and lozenges for home use. Prosecutors say he trained Perry’s assistant, Kenneth Iwamasa (who has pleaded guilty), to administer doses and provided additional vials for storage. The filings place a series of transactions between 30 September and 12 October 2023 as part of the conduct that led to charges.
Analysis & implications
The sentence sets an early federal benchmark in a case that intertwines medical practice, addiction treatment and criminal liability. Courts will weigh not only the quantity and timing of supplies but also whether a prescribing physician knowingly exploited an at-risk patient for payment. Regulators and professional boards may look to this case when assessing disciplinary standards for clinicians who provide controlled substances outside established clinical protocols.
For addiction treatment practice, the case underscores tensions between compassionate off-label use of medicines like ketamine and the risks of diversion or unsupervised administration. Clinics that offer such therapies face increased scrutiny over record-keeping, consent processes and safeguards to prevent excess dosing and third-party distribution. The involvement of multiple intermediaries and training of non-medical staff to inject controlled substances raises specific regulatory and criminal concerns.
Legally, the relatively short federal sentence compared with statutory maximums reflects plea bargaining dynamics and the judge’s application of sentencing guidelines, but it may not satisfy families seeking a longer punishment. The upcoming sentencing hearings for the four other defendants will further shape how prosecutors characterize culpability across medical and non-medical actors. Policymakers and medical associations could respond with tightened guidance or new oversight mechanisms targeting clinics that treat mental health conditions with controlled substances.
Comparison & data
| Item | Detail |
|---|---|
| Sentence | 30 months federal prison |
| Fine | $5,600 (≈£4,195) |
| Charges pleaded | Four counts of distributing ketamine |
| Maximum statutory exposure | Up to 40 years (per charging documents) |
| Prosecutor recommendation | Three years |
| Key transaction dates | 30 Sep–12 Oct 2023 (twenty 5 ml vials reported) |
The table above places the court outcome beside the original charging exposure and the prosecutors’ requested term, showing how plea agreements and guideline calculations narrowed sentencing. The fine and immediate remand reflect the federal court’s disposition that Plasencia’s conduct warranted both incarceration and financial penalty. Further sentencing of co-defendants will provide comparative data on how non-medical suppliers and other clinicians are treated in the same investigation.
Reactions & quotes
Family members used victim impact statements and courtroom remarks to emphasise harm and perceived betrayal by a physician. Their comments framed the sentence as part of accountability and also as insufficient reparation for the loss.
“There was nothing moronic about that man.”
Suzanne Morrison, Matthew Perry’s mother (victim statement)
Suzanne Morrison addressed Plasencia directly in court, citing text messages in filings and arguing that a doctor took an oath to protect patients rather than exploit them. Her statement underscored the family’s grief and their view that Plasencia bore primary responsibility.
“Matthew’s recovery counted on you saying NO.”
John and Debbie Perry, father and stepmother (victim statement)
In their joint letter to the court, Perry’s father and stepmother framed the doctor’s decisions as pivotal to their son’s fate and asked the judge to consider the broader impact on the family. They characterized the loss as devastating and urged a prison term reflecting that harm.
“There is no excuse. I can’t undo what’s been done.”
Dr. Salvador Plasencia (in-court statement)
Plasencia, who told the court he has a two-year-old son and surrendered his medical licence, expressed remorse and accepted responsibility in brief remarks. He apologised to Perry’s family and said he understood his actions could not be undone.
Unconfirmed
- Whether a single specific dose administered by any defendant was the direct, proximate cause of Perry’s death remains a matter described in court filings and will be clarified in pending documents and coroner findings.
- The full operational role and identities behind the person prosecutors referred to as the “Ketamine Queen” have not been publicly detailed beyond charging documents and plea agreements.
- Precise medical records showing every prescription, supervised infusion and unsanctioned administration leading up to Perry’s death have not been fully released in public filings.
Bottom line
The sentence of 30 months marks the first federal punishment in a high-profile probe that blurred medical practice and criminal distribution of a controlled substance. It highlights how clinicians can face criminal liability when they supply powerful drugs to vulnerable patients outside accepted safeguards, especially where money and informal networks intersect with addiction.
For families, the outcome is a form of legal accountability; for medicine and law, it is a signal that regulators and prosecutors will scrutinise off-protocol use of drugs like ketamine. The upcoming sentences for the other defendants, and any regulatory or licensing actions against clinicians, will determine whether this case produces broader changes in oversight and clinical practice.
Sources
- BBC News (UK broadcaster) — original reporting on sentencing, court filings and family statements.